Exenterative Surgery for Locally advanced and recurrent rectal, anal, vaginal & vulval cancers

Fri 27 September 2019 to Fri 27 September 2019, The Royal Marsden Education and Conference Centre, Stewart’s Grove, London SW3 6JJ

Exenterative Surgery for locally advanced and recurrent rectal, anal, vaginal & vulval cancers: Current and Future managements

For many years pelvic exenteration has been undertaken at the Royal Marsden. The most common indication is recurrent pelvic cancer in previously irradiated patients who in addition often have also had chemotherapy and pelvic surgery. Pelvic exenteration is performed with curative intent in almost all cases.

Following on from last year’s two-day meeting, this one-day conference is devoted to the current and future management of exenterative surgery for locally advanced recurrent rectal, anal, vaginal & vulval cancers.

Although these operations are numerically a relatively small part of the practice of colorectal, urological and gynaecological cancer surgeons, they are resource and labour-intensive, requiring long operating times, intensive care and long hospitalisation. Key considerations are case selection, and a well-planned and coordinated team approach involving diagnostic specialists, surgical specialists including plastic and reconstructive surgeons, anaesthetists and clinical nurse specialists. The balance is to maximise outcome in terms of survival but minimise the short and long term morbidity, maintaining or improving the patient’s quality of life. The conference will highlight current practice, recent improvements and innovations and take an optimistic and realistic look at future directions.

We do hope you will be able to join us for this exciting and challenging event.

RM


Barna. British Anaesthetic and Recovery Nurses Association